Data / Form D filings / Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc.: Form D filings
Tempest Therapeutics, Inc., a health care company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2011 and 2020. The latest, on February 12, 2020, reports $83.2 million sold of a $100.2 million offering to 10 investors.
Find out what Tempest Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7000 Shoreline Court, SUITE 275, South San Francisco, CA, 94080
- Phone
- (415) 798-8589
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1533635
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2020 | Amendment | $100,186,733 | $83,186,733 | $17,000,000 | 10 | Feb 16, 2018 | sec.gov |
| Feb 27, 2019 | Amendment | $70,186,738 | $48,186,738 | $22,000,000 | 8 | Feb 16, 2018 | sec.gov |
| Mar 1, 2018 | New notice | $70,186,738 | $25,186,738 | $45,000,000 | 8 | Feb 16, 2018 | sec.gov |
| Nov 23, 2011 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 2 | Oct 5, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas W. Dubensky, Jr. | Executive Officer, Director | |
| Paul W. Grayson | Director | |
| Petpiboon W. Prasit | Director | |
| Thomas W. Woiwode | Director | |
| Stella W. Xu | Director | |
| Robert W. Weisskoff | Director | |
| Michael W. Raab | Director | |
| Keting W. Chu | Director |
Other health care companies in California that filed recently
- Helande Innovations, Inc. $50,000 · Nov 6, 2026
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
- iPill Inc. $1.3 million · Oct 13, 2026
- White Eagle Sonic Technologies, Inc. $385,000 · Oct 13, 2026
- Digestive Disease Center, L.P. offering · Oct 8, 2026
- Xcelerated Recovery LLC $540,000 · Oct 2, 2026
- Lumati Holdings, Inc. $2.6 million · Oct 1, 2026
- Upstream Metabolics, Inc. $50,000 · Sep 29, 2026
- PFARADIGM Health, Inc. $31.1 million · Sep 28, 2026
- Alpfa Medical, Inc. $80.3 million · Sep 28, 2026
Every Form D from the week of Feb 10, 2020 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Tempest Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.